The pathophysiology of human obstructive cholestasis is mimicked in cholestatic Gold Syrian hamsters

被引:16
作者
van Golen, Rowan F. [1 ]
Olthof, Pim B. [1 ]
de Haan, Lianne R. [1 ]
Coelen, Robert J. [1 ]
Pechlivanis, Alexandros [2 ]
de Keijzer, Mark J. [1 ]
Weijer, Ruud [1 ]
de Waart, Dirk R. [3 ]
van Kuilenburg, Andre B. P. [4 ]
Roelofsen, Jeroen [4 ]
Gilijamse, Pim W. [1 ]
Maas, Martinus A. [1 ]
Lewis, Matthew R. [2 ,5 ]
Nicholson, Jeremy K. [2 ,5 ]
Verheij, Joanne [6 ]
Heger, Michal [1 ,7 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Expt Surg, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Dept Surg & Canc, Div Computat Syst & Digest Med, South Kensington Campus, London SW7 2AZ, England
[3] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Disorders, Amsterdam, Netherlands
[5] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, MRC NIHR Natl Phenome Ctr, London W12 0NN, England
[6] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands
[7] Univ Utrecht, Inst Biomembranes, Bijvoet Ctr Biomol Res, Membrane Biochem & Biophys, Utrecht, Netherlands
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2018年 / 1864卷 / 03期
基金
英国医学研究理事会;
关键词
Cholestasis; Muricholic acid; Cholangiocarcinoma; Bile duct ligation; Hepatostat; Gut-liver axis; Fgf15/FGF19; Liver fibrosis; Cholangiopathy; Cholangiocytes; FARNESOID-X RECEPTOR; GROWTH-FACTOR; 19; PRIMARY BILIARY-CIRRHOSIS; BILE-ACID METABOLISM; DUCT-LIGATED MICE; CHENODEOXYCHOLIC ACID; LIVER-REGENERATION; HUMAN HEPATOCYTES; CELL-DEATH; EXPRESSION;
D O I
10.1016/j.bbadis.2017.11.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Obstructive cholestasis causes liver injury via accumulation of toxic bile acids (BAs). Therapeutic options for cholestatic liver disease are limited, partially because the available murine disease models lack translational value. Profiling of time-related changes following bile duct ligation (BDL) in Gold Syrian hamsters revealed a biochemical response similar to cholestatic patients in terms of BA pool composition, alterations in hepatocyte BA transport and signaling, suppression of BA production, and adapted BA metabolism. Hamsters tolerated cholestasis well for up to 28 days and progressed relatively slowly to fibrotic liver injury. Hepatocellular necrosis was absent, which coincided with preserved intrahepatic energy levels and only mild oxidative stress. The histological response to cholestasis in hamsters was similar to the changes seen in 17 patients with prolonged obstructive cholestasis caused by cholangiocarcinoma. Hamsters moreover upregulated hepatic fibroblast growth factor 15 (Fgf15) expression in response to BDL, which is a cytoprotective adaptation to cholestasis that hitherto had only been documented in cholestatic human livers. Hamster models should therefore be added to the repertoire of animal models used to study the pathophysiology of cholestatic liver disease.
引用
收藏
页码:942 / 951
页数:10
相关论文
共 57 条
[1]
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification [J].
Alnouti, Yazen .
TOXICOLOGICAL SCIENCES, 2009, 108 (02) :225-246
[2]
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration [J].
Alvarez-Sola, Gloria ;
Uriarte, Iker ;
Ujue Latasa, M. ;
Fernandez-Barrena, Maite G. ;
Urtasun, Raquel ;
Elizalde, Maria ;
Barcena-Varela, Marina ;
Jimenez, Maddalen ;
Chang, Haisul C. ;
Barbero, Roberto ;
Catalan, Victoria ;
Rodriguez, Amaia ;
Fruhbeck, Gema ;
Gallego-Escuredo, Jose M. ;
Gavalda-Navarr, Aleix ;
Villarroya, Francesc ;
Rodriguez-Ortigosa, Carlos M. ;
Corrales, Fernando J. ;
Prieto, Jesus ;
Berraondo, Pedro ;
Berasain, Carmen ;
Avila, Matias A. .
GUT, 2017, 66 (10) :1818-1828
[3]
The cytostatic- and differentiation-inducing effects of cyclopentenyl cytosine on neuroblastoma cell lines [J].
Bierau, J ;
van Gennip, AH ;
Helleman, J ;
van Kuilenburg, ABP .
BIOCHEMICAL PHARMACOLOGY, 2001, 62 (08) :1099-1105
[4]
BOYD GS, 1966, J LIPID RES, V7, P83
[5]
Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters [J].
Castro-Perez, Jose ;
Briand, Francois ;
Gagen, Karen ;
Wang, Sheng-Ping ;
Chen, Ying ;
McLaren, David G. ;
Shah, Vinit ;
Vreeken, Rob J. ;
Hankemeier, Thomas ;
Sulpice, Thierry ;
Roddy, Thomas P. ;
Hubbard, Brian K. ;
Johns, Douglas G. .
JOURNAL OF LIPID RESEARCH, 2011, 52 (11) :1965-1973
[6]
Social stress and reproductive success in the female Syrian hamster: Endocrine and behavioral correlates [J].
Chelini, Marie Odile Monier ;
Palme, Rupert ;
Otta, Emma .
PHYSIOLOGY & BEHAVIOR, 2011, 104 (05) :948-954
[7]
Management of cholestatic disease in 2017 [J].
de Vries, Elsemieke ;
Beuers, Ulrich .
LIVER INTERNATIONAL, 2017, 37 :123-129
[8]
The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling [J].
Drafahl, Kristine A. ;
McAndrew, Christopher W. ;
Meyer, April N. ;
Haas, Martin ;
Donoghue, Daniel J. .
PLOS ONE, 2010, 5 (12)
[9]
A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever [J].
Ebihara, Hideki ;
Zivcec, Marko ;
Gardner, Donald ;
Falzarano, Darryl ;
LaCasse, Rachel ;
Rosenke, Rebecca ;
Long, Dan ;
Haddock, Elaine ;
Fischer, Elizabeth ;
Kawaoka, Yoshihiro ;
Feldmann, Heinz .
JOURNAL OF INFECTIOUS DISEASES, 2013, 207 (02) :306-318
[10]
Oncosis represents the main type of cell death in mouse models of cholestasis [J].
Fickert, P ;
Trauner, M ;
Fuchsbichler, A ;
Zollner, G ;
Wagner, M ;
Marschall, HU ;
Zatloukal, K ;
Denk, H .
JOURNAL OF HEPATOLOGY, 2005, 42 (03) :378-385